HUMAN IMMUNODEFICIENCY VIRUS

This study is testing a new clinic program called CHIMES, designed to better connect HIV care with mental health support. It focuses on young Black gay and bisexual men living with HIV in Atlanta. The goal is to see if this integrated approach helps people stay engaged with their…

This study tests two support programs to help HIV-positive teenagers in South Africa successfully move from pediatric to adult healthcare. Researchers are comparing in-person support groups with a mobile health (mHealth) app approach against standard care. The goal is to see whic…

This study is testing whether a vaginal insert containing the drug artesunate can help clear HPV infection in women living with HIV who have recently received standard treatment for cervical precancer. 120 participants will use either the active insert or a placebo for several we…

This study aimed to test a combined monthly injection treatment for people living with both HIV and opioid addiction. The goal was to see if giving both medications in one visit was practical and acceptable to patients and clinic staff. The study was withdrawn before any particip…

This early-stage study is testing a new combination treatment for HIV. It involves two lab-made antibodies and an immune system booster. The goal is to see if this combo is safe and can control the virus well enough for participants to safely stop their daily antiviral pills for …

This study is testing a new coaching program to help nurses better manage high blood pressure in patients who are also living with HIV. It involves 830 adults with uncontrolled blood pressure across 30 primary health clinics in Nigeria. The goal is to see if providing nurses with…

This study is testing whether computer algorithms can help HIV clinics in Kenya improve patient care. The algorithms will try to predict which patients are most likely to miss appointments or have their treatment stop working. Clinics that use these predictions will be compared t…

This study is testing whether delivering HIV prevention medication (PrEP) directly to people in their communities is more effective than requiring them to visit clinics. It involves 2,500 young women and men in South Africa who are at high risk for HIV. The goal is to see if this…